Clinical Trial Update: Safety and Tolerability of I-040302 in Children and Young Adults With Solitary Bone Cysts [Phase 2]

View source ↗

Summary

A Phase 2 trial of I-040302 for solitary bone cysts in children and young adults has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solitary Bone Cyst

Drugs mentioned

• I-040302

Snippet

Sponsor: Kuros Biosurgery AG | Conditions: Bone Cysts | Phase 2 | Status: WITHDRAWN